Heart failure prevalence and predictors in Turkey: HAPPY study;Türkiye'deki kalp yetersizliǧi prevalansi ve öngördürücüleri: HAPPY çalişmasi

Turk Kardiyoloji Dernegi Arsivi

Volumn 40, Issue 4, 2012, Pages 298-308

  Deǧertekin, Muzaffer ^a   Erol, Çetin ^b   Ergene, Oktay ^c   Tokgözoǧlu, Lale ^d   Aksoy, Mehmet ^e   Erol, Mustafa Kemal ^f   Eren, Mehmet ^g   Şahin, Mahmut ^h   Eroǧlu, Elif ^a   Mutlu, Bülent ⁱ   Kozan, Ömer ^j  

^a YEDITEPE UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c Acil Tip ABD   (Turkey)

^d HACETTEPE UNIVERSITY   (Turkey)

^e GAZIANTEP UNIVERSITY   (Turkey)

^f Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center   (Turkey)

^g DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^h 19 Mayis Üniversitesi Tip Fakültesi Tibbi Mikrobiyoloji Anabilim Dali   (Turkey)

ⁱ MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^j DOKUZ EYLUL UNIVERSITY   (Turkey)

more..

Author keywords

Biological markers; Echocardiography; Heart failure epidemiology etiology; Natriuretic peptide, brain blood; Turkey epidemiology

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGE DISTRIBUTION; ARTICLE; ASYMPTOMATIC LEFT VENTRICULAR DYSFUNCTION; BODY HEIGHT; BODY WEIGHT; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; OBESITY; PREDICTOR VARIABLE; PREVALENCE; TREATMENT INDICATION; TURKEY (REPUBLIC); WAIST HIP RATIO; AGE; AGED; BLOOD; COMPLICATION; HEART DISEASE; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; RISK FACTOR; SEX DIFFERENCE; TURKEY;

ADULT; AGE FACTORS; AGED; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART DISEASES; HEART FAILURE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREVALENCE; RISK FACTORS; SEX FACTORS; TURKEY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84877628275     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: 10.5543/tkda.2012.65031     Document Type: Article

References (29)

1. Sanderson JE, Tse TF. Heart failure: a global disease requiring a global response. Heart 2003;89:585-6. [CrossRef] (Pubitemid 36606191)
2. Mair FS, Crowley TS, Bundred PE. Prevalence, aetiology and management of heart failure in general practice. Br J Gen Pract 1996;46:77-9. (Pubitemid 26056094)
3. Kannel WB. Incidence and epidemiology of heart failure. Heart Fail Rev 2000;5:167-73. [CrossRef]
4. Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, Sutton GC, et al. The epidemiology of heart failure. Eur Heart J 1997;18:208-25. [CrossRef] (Pubitemid 27107582)
5. Campbell DJ. Heart failure: how can we prevent the epidemic? Med J Aust 2003;179:422-5. (Pubitemid 37328008)
6. Bertoni AG, Hundley WG, Massing MW, Bonds DE, Burke GL, Goff DC Jr. Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care 2004;27:699-703. [CrossRef] (Pubitemid 38280536)
7. Lavie CJ, Milani RV, Ventura HO, Romero-Corral A. Body composition and heart failure prevalence and prognosis: getting to the fat of the matter in the "obesity paradox". Mayo Clin Proc 2010;85:605-8. [CrossRef]
8. Baena-Díez JM, Byram AO, Grau M, Gómez-Fernández C, Vidal-Solsona M, Ledesma-Ulloa G, et al. Obesity is an independent risk factor for heart failure: Zona Franca Cohort study. Clin Cardiol 2010;33:760-4. [CrossRef]
9. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119:1977-2016. [CrossRef]
10. Palazzuoli A, Gallotta M, Quatrini I, Nuti R. Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure. Vasc Health Risk Manag 2010;6:411-8. [CrossRef]
11. Betti I, Castelli G, Barchielli A, Beligni C, Boscherini V, De Luca L, et al. The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study. J Card Fail 2009;15:377-84. [CrossRef]
12. American College of Cardiology Foundation Appropriate Use Criteria Task Force; American Society of Echocardiography; American Heart Association; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Critical Care Medicine; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance; American College of Chest Physicians, Douglas PS, Garcia MJ, Haines DE, Lai WW, Manning WJ, Patel AR, et al. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. J Am Soc Echoeardiogr 2011;24:229-67. [CrossRef]
13. http://www.tuik.gov.tr.
14. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999;33:1948-55. [CrossRef]
15. Davies M, Hobbs F, Davis R, Kenkre J, Roalfe AK, Hare R, et al. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study Lancet 2001;358:439-44. (Pubitemid 32769849)
16. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003;289:194-202. (Pubitemid 36068707)
17. McDonagh TA, Morrison CK, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJ, et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997;350:829-33. [CrossRef] (Pubitemid 27404343)
18. Aurigemma GP, Gottdiener JS, Shemanski L, Gardin J, Kitzman D. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study. J Am Coll Cardiol 2001;37:1042-8. (Pubitemid 32217604)
19. Bella JN, Palmieri V, Roman MJ, Liu JE, Welty TK, Lee ET, et al. Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study. Circulation 2002;105:1928-33. [CrossRef] (Pubitemid 34437620)
20. Gottdiener JS, McClelland RL, Marshall R, Shemanski L, Furberg CD, Kitzman DW, et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med 2002;137:631-9. (Pubitemid 35176095)
21. Hobbs FD, Roalfe AK, Davis RC, Davies MK, Hare R; Midlands Research Practices Consortium (MidReC). Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES). Eur Heart J 2007;28:1128-34. [CrossRef] (Pubitemid 47343888)
22. Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 2003;108:977-82. [CrossRef] (Pubitemid 37048228)
23. Cohn JN, Johnson G. Heart failure with normal ejection fraction. The V-HeFT Study. Veterans Administration Cooperative Study Group. Circulation 1990;81:III48-53.
24. Ghali JK, Kadakia S, Bhatt A, Cooper R, Liao Y. Survival of heart failure patients with preserved versus impaired systolic function: the prognostic implication of blood pressure. Am Heart J 1992;123:993-7. [CrossRef]
25. Setaro JF, Soufer R, Remetz MS, Perlmutter RA, Zaret BL. Long-term outcome in patients with congestive heart failure and intact systolic left ventricular performance. Am J Cardiol 1992;69:1212-6. [CrossRef]
26. Onat A. Türkiye' de obezitenin kardiyovaskliler hastahklara etkisi. Türk Kardiyol Dern Arş 2003;31:273-82.
27. Onat A. Fiziksel etkinlik, metabolik bozukluklardan korunma ve koroner mortalite. In: Onat A, editör. Türk halkinin kalp saǧliǧ i. İstanbul: Argos-cortex; 2007. s. 140-5.
28. Engberding M, Wenger NK. Cardiovascular disease prevention tailored for women. Expert Rev Cardiovasc Ther 2008;6:1123-34. [CrossRef]
29. Kozan Ö, Oǧuz A, Abaci A, Erol C, Öngen Z, Temizhan A ve ark. Prevalence of metabolic syndrome among Turkish adults. Eur J Clin Nutr 2007;31:548-53. (Pubitemid 46605227)